At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 target
Drug / intervention
Probiotics-Bio-plusdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Probiotics for the Prevention of Major Complications of Cirrhosis
In Brief
A clinical study evaluating Probiotics-Bio-plus for Liver Cirrhosis. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether probiotics are effective in the prevention of the complications of liver cirrhosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cirrhosis
CountriesIsrael
CollaboratorsAmbrosia - SupHerb Ltd.
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2005
First PostedApr 2006
Study CompletionOct 2007
TodayJul 2026
First PostedApr 11, 2006
Enrollment StartApr 1, 2005
Study CompletionOct 1, 2007
TodayJul 2, 2026
Posted 20.2 years ago
Interventions
Probiotics-Bio-plusdrug